Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Diabetes and Endo
    • ACP Recommendations of...

    ACP Recommendations of HBA1C between 7%-8% NOT APPLICABLE to Indian Diabetics- Dr Shashank Joshi

    Written by Anjali Nimesh Nimesh Published On 2018-03-07T16:35:45+05:30  |  Updated On 23 Dec 2022 10:36 AM IST
    ACP Recommendations of HBA1C between 7%-8% NOT APPLICABLE to Indian Diabetics- Dr Shashank Joshi




    An HbA1C test measures a person's average blood sugar level over the past two or three months. Generally An HbA1C of 6.5 percent indicates diabetes.

    However, according to new recommendations of American College of Physicians (ACP) there is no proof of benefit for targets of HbA1c below 7%. Therefore, in an evidence-based guidance statement, ACP has suggested that HbA1c between 7% & 8% was okay for most T2 DM patients. This implies that most patients with type 2 diabetes should be treated to achieve an A1C between 7 percent and 8 percent rather than 6.5 percent to 7 percent published todayThe updated guidance has been published online in Annals of Internal Medicine

    Read ALso: HbA1c between 7% and 8% okay for T2DM Patients-New ACP Guidelines

    Refuting the guidelines in the Indian Perspective, Dr Shashank R Joshi leading Endocrinologist in Mumbai and Member Editorial Board, Diabetology at Specialty Medical Dialogues, stated that these guidelines do not apply in the Indian context
    "The current ACP guidance for Type 2 diabetes don't apply to the Indian population.Indians have our own ICMR, RSSDI and API recommendations.also, Indians have different phenotype, genotype as well as lifestyle issues.For Asian Indian, we need to transcultural our own recommendations based on our food and activity. Also, we have now our own Indian evidence base.This guidance now creates confusion in the USA because expert bodies like ADA and AACE have glycosylated Hb at 7 and 6.5 while ACP which is an internist body speaks about 7 to 8. What we need to learn from ACP recommendations is the need to individualize and personalized diabetes care," stated Dr Shashank Joshi,




    He added that the guidelines are now adding to the confusion for the Indian medical practitioners at large. "ACP in an attempt to simply for generalist or internist have attempted to create confusion between experts and generalists. Moreover, it will lead to confusion with doctors and patients when they see conflicting views.Fortunately, in India, we don't have such confusion and we should never follow us recommendation because they are meant for their race and geography, not outs.Indians Chinese as well as Asians eat more carbohydrates and therefore both doses to responses of our population to medicines is different." he added


    Kindly Provide your Opinion below

    [yop_poll id="1"]
    diabetesDiabetes CareDr Shashank JoshiEndocrinologistglycosylatedHbA1cICMRIndian Academy of DiabetesShashank Joshi

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Anjali Nimesh Nimesh
    Anjali Nimesh Nimesh
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok